Last reviewed · How we verify
NCT03538288
Feasibility Trial of rTMS for Cannabis Use Disorder
NA trial testing rTMS in Cannabis in 3 participants. Completed in 1 July 2017.
1 July 2017
Quick facts
| Lead sponsor | Medical University of South Carolina |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 3 |
| Start date | 1 October 2016 |
| Primary completion | 1 July 2017 |
| Estimated completion | 1 July 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- rTMS
Conditions studied
- Cannabis — all drugs for Cannabis →
Sponsor
Medical University of South Carolina
Who can join
Adults 18 to 60, female only, with Cannabis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This small pilot trial will recruit 10 cannabis use disordered participants and apply 20 sessions of rTMS in conjunction with a two session Brief Marijuana Dependance Counseling treatment paradigm. The investigators are primarily seeking to determine if the proposed paradigm is feasible and well tolerated.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A case series exploring the effect of twenty sessions of repetitive transcranial magnetic stimulation (rTMS) on cannabis use and craving.
Sahlem GL, Caruso MA, Short EB, Fox JB, et al · · 2020 · cited 16× · PMID 31619347 · DOI 10.1016/j.brs.2019.09.014 -
Tolerability and feasibility of accelerated repetitive transcranial stimulation for reduction of nicotine craving.
Friedrich D, Li X, Hartwell KJ, Short EB, et al · · 2019 · cited 2× · PMID 31253502 · DOI 10.1016/j.brs.2019.06.023
Verify or expand the search:
- PubMed search for NCT03538288
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of rTMS
Trials testing the same drug.
- NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
- NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
- NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
- NCT07451600 — Effectiveness of TMS on Spasticity and Balance for Patients With MS · NA · recruiting
- NCT04532190 — Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder · NA · recruiting
Other recruiting trials for Cannabis
Currently open trials in the same condition.
- NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
- NCT07417059 — Sex Hormones Impact on Cannabis Response · NA · recruiting
- NCT07194018 — Use of Cannabis Oil in Fibromyalgia · active not recruiting
- NCT06099379 — Modulation of THC Effects by CBD: a Dose-ranging Study · Phase 1, PHASE2 · recruiting
- NCT05742724 — The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol · Phase 1 · active not recruiting
Other Medical University of South Carolina trials
Trials by the same sponsor.
- NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
- NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
- NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
- NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03538288 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
- Last refreshed: 2 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03538288.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing